Identification of broadly tumour-reactive γδ TCRs from multiple myeloma

Researchers have developed a machine-learning algorithm called PreGame to identify tumour-reactive γδ T cells in cancer patients. This tool helps distinguish these cells from bystanders, potentially accelerating the development of new immunotherapies.
Why it matters
Advances in identifying specific immune cell functions could lead to more effective, personalized cancer treatments.
γδ T cells are becoming increasingly appreciated for their antitumour capacity and role in mediating responses to immune checkpoint blockade 1 , 2 , 3 . Unlike classical αβ T cells, the degree to which γδ T cells rely on their T cell receptors (TCRs) to induce antitumour responses remains unclear. The challenge of distinguishing γδ T cells with tumour-reactive TCRs from bystander γδ T cells limits our understanding of tumour-reactive γδ T cell biology and the translation of their TCRs into immunotherapeutics. Here we present PreGame, a machine-learning algorithm capable of identifying tumour-reactive γδ T cells from single-cell CITE sequencing data. We use PreGame to identify tumour-reactive γδ T cells from patients with multiple myeloma or other solid cancers, and confirm the specificity of their TCRs to tumour cells.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in